US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$281.73
▼-12.48%
MSFT
$530.14
▼-0.16%
MU
$934.27
▼-4.98%
META
$624.52
▲+1.96%
AMZN
$243.79
▼-4.25%
NVDA
$213.60
▼-0.83%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$281.73
▼-12.48%
MSFT
$530.14
▼-0.16%
MU
$934.27
▼-4.98%
META
$624.52
▲+1.96%
AMZN
$243.79
▼-4.25%
NVDA
$213.60
▼-0.83%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about XCNQ:MBIO
Recent news which mentions XCNQ:MBIO
Mindbio Announces Intention To Refile MD & A
February 14, 2025
Tickers
MBIO
Tags
MindBio Therapeutics
en/US
#Mining
From
TheNewswire.com - RSS (Media)
Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer
October 24, 2024
Tickers
MBIO
Tags
MindBio Therapeutics
#Mining
#Psychedelics
From
TheNewswire.com - RSS (Media)